James "Jimi" Stewart, a 39-year-old man from Texas, was diagnosed with non-muscle-invasive bladder cancer at age 39, two decades before most people develop the disease. Stewart, who was otherwise healthy, found blood in his urine a key warning sign of bladder cancer. He underwent bladder removal surgery and was introduced to INLEXZO, a new treatment advancement that was FDA-approved in 2025. Stewart was the first commercial patient in Texas to receive this treatment, which involves a drug-releasing system placed directly into the bladder by a urologist. He has since been declared cancer-free and is currently approaching his eighth and final dose of INLEEXZO.